
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About


Canopy Growth Corp (CGC)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/13/2025: CGC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Year Target Price $2.28
Year Target Price $2.28
0 | Strong Buy |
2 | Buy |
4 | Hold |
0 | Under performing |
4 | Sell |
Analysis of Past Performance
Type Stock | Historic Profit -48.89% | Avg. Invested days 16 | Today’s Advisory WEAK BUY |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 264.01M USD | Price to earnings Ratio - | 1Y Target Price 2.31 |
Price to earnings Ratio - | 1Y Target Price 2.31 | ||
Volume (30-day avg) - | Beta 2.14 | 52 Weeks Range 0.77 - 8.65 | Updated Date 06/29/2025 |
52 Weeks Range 0.77 - 8.65 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -4.1 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -222.35% | Operating Margin (TTM) -6.09% |
Management Effectiveness
Return on Assets (TTM) -3.63% | Return on Equity (TTM) -122.33% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 390462302 | Price to Sales(TTM) 0.98 |
Enterprise Value 390462302 | Price to Sales(TTM) 0.98 | ||
Enterprise Value to Revenue 1.98 | Enterprise Value to EBITDA -1.06 | Shares Outstanding 186892000 | Shares Floating 185107022 |
Shares Outstanding 186892000 | Shares Floating 185107022 | ||
Percent Insiders 0.93 | Percent Institutions 8.27 |
Analyst Ratings
Rating 2.5 | Target Price 2.28 | Buy 2 | Strong Buy - |
Buy 2 | Strong Buy - | ||
Hold 4 | Sell 1 | Strong Sell 3 | |
Strong Sell 3 |
Upturn AI SWOT
Canopy Growth Corp

Company Overview
History and Background
Canopy Growth Corp, formerly Tweed Marijuana Inc., was founded in 2013 in Smiths Falls, Ontario, Canada. It was one of the first publicly traded cannabis companies in North America. It has grown through acquisitions and partnerships to become a major player in the cannabis industry.
Core Business Areas
- Cannabis Beverages: Production and distribution of cannabis-infused beverages, including ready-to-drink options and beverage enhancers.
- Dried Flower and Pre-Rolls: Cultivation and sale of dried cannabis flower and pre-rolled joints under various brands.
- Edibles: Production and sale of cannabis-infused edibles, such as gummies, chocolates, and baked goods.
- Vaporizers: Sale of vaporizers and cannabis oil cartridges.
- CBD Products: Sale of CBD-based products, including oils, creams, and edibles, under various brands.
Leadership and Structure
David Klein serves as the Chief Executive Officer. The company operates with a board of directors and various executive leadership positions overseeing different business segments.
Top Products and Market Share
Key Offerings
- Tweed Dried Flower: A wide range of dried cannabis flower strains. Market share data is difficult to pinpoint exactly for individual strains but Tweed is a top seller within Canopy's portfolio. Competitors include Aurora Cannabis, Tilray, and Organigram.
- Deep Space Cannabis Beverages: Cannabis-infused beverages offering a convenient and controlled consumption method. Market share is growing within the beverage category. Competitors include Truss Beverage Co. and other craft beverage companies.
- Ace Valley Gummies: Cannabis-infused gummies in a variety of flavors and strengths. Edibles are a fast-growing segment. Competitors include Wana Brands and other edibles manufacturers.
- Storz & Bickel Vaporizers: High end vaporizers such as Volcano Classic and Mighty+. Market share is strong within premium vaporizer segment. Competitors include PAX Labs and DaVinci.
Market Dynamics
Industry Overview
The cannabis industry is experiencing rapid growth, driven by increasing legalization and changing consumer attitudes. The market is becoming more competitive, with new players entering and established companies expanding their product offerings.
Positioning
Canopy Growth Corp aims to be a leader in the global cannabis market. They have invested heavily in research and development, production infrastructure, and brand building. They also have strategic partnerships with other companies. The recent focus is on cost reduction and profitability.
Total Addressable Market (TAM)
The global cannabis market is projected to reach hundreds of billions of USD in the coming years. Canopy Growth Corp is positioned to capture a significant portion of this TAM through its diverse product portfolio and global presence.
Upturn SWOT Analysis
Strengths
- Strong brand recognition
- Extensive production infrastructure
- Global presence
- Strategic partnerships
- Diverse product portfolio
Weaknesses
- High operating costs
- Inconsistent profitability
- Dilution of shareholder value
- Regulatory uncertainty
- Intense competition
Opportunities
- Further legalization of cannabis in new markets
- Expansion of product offerings
- Strategic acquisitions
- Development of new technologies
- Increased consumer demand for cannabis products
Threats
- Intense competition
- Regulatory changes
- Fluctuations in cannabis prices
- Economic downturns
- Negative perception of cannabis
Competitors and Market Share
Key Competitors
- TLRY
- ACB
- CRON
Competitive Landscape
Canopy Growth Corp faces intense competition from other large cannabis companies, as well as smaller players. The company's advantages include its brand recognition and global presence, but its disadvantages include its high costs and inconsistent profitability.
Major Acquisitions
Supreme Cannabis
- Year: 2021
- Acquisition Price (USD millions): 346
- Strategic Rationale: Expanded Canopy Growth's brand portfolio and production capacity. It was intended to provide cost synergies but overall has not worked out as anticipated.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been characterized by rapid expansion followed by restructuring and cost-cutting initiatives.
Future Projections: Analyst projections vary widely, with some forecasting growth and others anticipating continued challenges. Achieving profitability is a key factor in future growth.
Recent Initiatives: Recent initiatives include cost reduction programs, streamlining operations, and focusing on core markets.
Summary
Canopy Growth Corp is a major player in the cannabis industry with strong brand recognition, but it struggles with profitability and high operating costs. It needs to streamline operations and focus on achieving profitability in key markets. Regulatory changes and increasing competition pose significant risks to the company's future. The company's future growth depends on its ability to successfully execute its turnaround strategy and capitalize on emerging opportunities in the global cannabis market.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Market Research Reports
- Analyst Estimates
- Industry News Sources
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. The cannabis industry is rapidly evolving, and market conditions can change quickly. Data may be delayed or inaccurate. Past performance is not indicative of future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Canopy Growth Corp
Exchange NASDAQ | Headquaters Smiths Falls, ON, Canada | ||
IPO Launch date 2014-04-04 | CEO & Director Mr. Luc Mongeau | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 960 | Website https://www.canopygrowth.com |
Full time employees 960 | Website https://www.canopygrowth.com |
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Wana, and Claybourne brands, as well as DOJA, LivRelief, Ace Valley, and Vert brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.